Literature DB >> 22053122

Dropout from interim methadone and subsequent comprehensive methadone maintenance.

Jan Gryczysnki1, Robert Schwartz, Kevin O'Grady, Jerome Jaffe.   

Abstract

BACKGROUND: Methadone maintenance in the U.S. is delivered primarily through specialized clinics that provide psychosocial services together with medication. Interim methadone (IM) is an evidence-based approach to increase access by providing methadone without counseling for individuals waiting for admission to comprehensive treatment. Little is known about the role of patient characteristics in predicting outcomes in the IM service pathway (IM with comprehensive methadone treatment following IM).
METHODS: This study examined the relationship between patient motivation and dropout among patients in the IM service pathway (n=183). Participants were assessed with the Addiction Severity Index, the Texas Christian University Motivation Scales, and study-specific instruments at baseline, 4 month follow-up or admission to comprehensive treatment (whichever occurred first), and 6 months thereafter. Multinomial logistic regression was used for the analysis, controlling for demographics, route of administration, cocaine use, criminal justice history, and treatment history.
RESULTS: Of the total sample, 62% were retained throughout the IM service pathway, 20% left IM, and 18% left subsequent comprehensive treatment. Motivation did not predict dropout from either IM or comprehensive treatment following IM. Unexpectedly, neither did any of the other explanatory variables included in the model.
CONCLUSIONS: Most patients remained in the IM service pathway. The patient characteristics examined are not associated with discontinuation of IM or subsequent comprehensive methadone treatment. SCIENTIFIC SIGNIFICANCE: The findings that most patients were retained in the IM service pathway, and that no subgroup experienced higher probability of dropout, bolster the public health potential of IM as a service strategy.

Entities:  

Year:  2009        PMID: 22053122      PMCID: PMC3205350          DOI: 10.3109/00952990903322865

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  20 in total

1.  Factors associated with methadone maintenance treatment retention among street-recruited injection drug users.

Authors:  Robert E Booth; Karen F Corsi; Susan K Mikulich-Gilbertson
Journal:  Drug Alcohol Depend       Date:  2004-05-10       Impact factor: 4.492

2.  A randomized controlled trial of interim methadone maintenance: 10-Month follow-up.

Authors:  Robert P Schwartz; Jerome H Jaffe; David A Highfield; Jason M Callaman; Kevin E O'Grady
Journal:  Drug Alcohol Depend       Date:  2006-06-21       Impact factor: 4.492

3.  Drug abuse treatment retention and process effects on follow-up outcomes.

Authors:  D D Simpson; G W Joe; G A Rowan-Szal
Journal:  Drug Alcohol Depend       Date:  1997-09-25       Impact factor: 4.492

4.  Premature discharge from methadone treatment: patient perspectives.

Authors:  Heather Schacht Reisinger; Robert P Schwartz; Shannon Gwin Mitchell; James A Peterson; Sharon M Kelly; Kevin E O'Grady; Erica A Marrari; Barry S Brown; Michael H Agar
Journal:  J Psychoactive Drugs       Date:  2009-09

Review 5.  An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research.

Authors:  Laura Amato; Marina Davoli; Carlo A Perucci; Marica Ferri; Fabrizio Faggiano; Richard P Mattick
Journal:  J Subst Abuse Treat       Date:  2005-06

6.  Drug abuse treatment process components that improve retention.

Authors:  D D Simpson; G W Joe; G A Rowan-Szal; J M Greener
Journal:  J Subst Abuse Treat       Date:  1997 Nov-Dec

7.  A randomized controlled trial of interim methadone maintenance.

Authors:  Robert P Schwartz; David A Highfield; Jerome H Jaffe; Joseph V Brady; Carol B Butler; Charles O Rouse; Jason M Callaman; Kevin E O'Grady; Robert J Battjes
Journal:  Arch Gen Psychiatry       Date:  2006-01

Review 8.  Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction.

Authors: 
Journal:  JAMA       Date:  1998-12-09       Impact factor: 56.272

9.  Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome.

Authors:  David A Highfield; Robert P Schwartz; Jerome H Jaffe; Kevin E O'Grady
Journal:  Addiction       Date:  2007-09-03       Impact factor: 6.526

10.  Accessibility of addiction treatment: results from a national survey of outpatient substance abuse treatment organizations.

Authors:  Peter D Friedmann; Stephenie C Lemon; Michael D Stein; Thomas A D'Aunno
Journal:  Health Serv Res       Date:  2003-06       Impact factor: 3.402

View more
  3 in total

1.  Heroin Use, HIV-Risk, and Criminal Behavior in Baltimore: Findings from Clinical Research.

Authors:  Robert P Schwartz; Sharon M Kelly; Jan Gryczynski; Shannon Gwin Mitchell; Kevin E O'Grady; Jerome H Jaffe
Journal:  J Addict Dis       Date:  2015

2.  Hospitalized opioid-dependent patients: Exploring predictors of buprenorphine treatment entry and retention after discharge.

Authors:  Christina S Lee; Jane M Liebschutz; Bradley J Anderson; Michael D Stein
Journal:  Am J Addict       Date:  2017-03-21

3.  Leaving buprenorphine treatment: patients' reasons for cessation of care.

Authors:  Jan Gryczynski; Shannon Gwin Mitchell; Jerome H Jaffe; Kevin E O'Grady; Yngvild K Olsen; Robert P Schwartz
Journal:  J Subst Abuse Treat       Date:  2013-10-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.